🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G72800108
- Market Cap
- Large Cap
- Previous Symbol
- PRTAV (changed 12/21/2012)
Business: Prothena Corporation is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally change the course of progressive, life-threatening diseases. Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets including Parkinson’s disease and other related synucleinopathies (prasinezumab - PRX002/RG7935) and ATTR amyloidosis (PRX004), as well as tau, Aβ (Amyloid beta) and TDP-43 where its scientific understanding of disease pathology can be leveraged.
Company Contact
- CEO
- Gene G. Kinney
- CFO
- Tran B. Nguyen
- Headquarters
- 650 Gateway Boulevard, South San Francisco, CA 94080
- Phone
- 650-837-8550
- Fax
- 650-837-8560
- Investor Relations
- Ellen Rose · 650-922-2405 · ellen.rose@prothena.com